Thrombin generation in severely obese children [3]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 8, 2006, Pages 1834-1836

  Cimenti, C ^a   Mangge, H ^a   Haidl, H ^a   Zach, D ^a   Muntean, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADOLESCENT; ALCOHOL CONSUMPTION; BLOOD CLOTTING TIME; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; INSULIN RESISTANCE; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; STRESS;

ADOLESCENT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; MALE; OBESITY; PILOT PROJECTS; RISK; THROMBIN; THROMBIN TIME; TIME FACTORS;

EID: 33746635483     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02038.x     Document Type: Letter

References (18)

1. Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obes Rev 2002; 3: 85-101.
2. Rosito GA, D'Agostino RB, Massaro J, Lipinska I, Mittleman MA, Sutherland P, Wilson PWF, Levy D, Muller JE, Tofler GH. Association between obesity and a prothrombotic state: The Framingham Offspring Study. Thromb Haemost 2004; 91: 683-9.
3. Guagnano MT, Romano M, Falco A, Nutini M, Marinopiccoli M, Manigrasso MR, Basili S, Davi G. Leptin increase is associated with markers of the hemostatic system in obese healthy women. J Thromb Haemost 2003; 1: 2330-4.
4. Gallistl S, Sudi KM, Borkenstein M, Troebinger M, Weinhandl G, Muntean W. Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obes Relat Metab Disord 2000; 24: 1459-64.
5. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS. The relation of childhood BMI to adult adiposity: The Bogalusa Heart Study. Pediatrics 2005; 115: 22-7.
6. Mangge H, Schauenstein K, Stroedter L, Griesl A, Maerz W, Borkenstein M. Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis. Exp Clin Endocrinol Diabetes 2004; 112: 378-82.
7. Lijnen HR. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 2005; 3: 35-45.
8. Berenson GS, Srinivasan SR, Bao W, Newman III WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338: 1650-6.
9. Mann KG, Brummel K, Butenas S. What is all that thrombin for? J Thromb Haemost 2003; 1: 1504-14.
10. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
11. Pilz S, Horejsi R, Möller R, Almer G, Scharnagl G, Stojakovic T, Dimitrova R, Weihrauch G, Borkenstein M, Maerz W, Schauenstein K, Mangge H. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 2005; 90: 4792-6.
12. De Pergola G, Pannacciulli N. Coagulation and fibrinolysis abnormalities in obesity. J Endocrinol Invest 2002; 25: 899-904.
13. Marutsuka K, Hatakeyama K, Yamashita A, Asada Y. Role of thrombogenic factors in the development of atherosclerosis. J Atheroscler Thromb 2005; 12: 1-8.
14. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-9.
15. Sudi KM, Gallistl S, Weinhandl G, Muntean W, Borkenstein MH. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Metabolism 2000; 49: 890-5.
16. Ferguson MA, Gutin B, Owens S, Litaker M, Tracy RP, Allison J. Fat distribution and hemostatic measures in obese children. Am J Clin Nutr 1998; 67: 1136-40.
17. Vambergue A, Rugeri L, Gaveriaux V, Devos P, Martin A, Fermon C, Fontaine P, Jude B. Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: Influence of type of diabetes, obesity index, and age. Thromb Res 2001; 101: 367-75.
18. Cvirn G, Gallistl S, Leschnik B, Muntean W. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost 2003; 1: 263-8.